▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Sysco Q2 22 Earnings Conference Call At 10:00 AM ET

By RTTNews Staff Writer ✉ | Published: 2/8/2022 6:00 AM ET

Sysco Corp. (SYY) will host a conference call at 10:00 AM ET on February 8, 2022, to discuss Q2 22 earnings results.

To access the live webcast, log on to https://investors.sysco.com/annual-reports-and-sec-filings/events-and-presentations/upcoming-events

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In October 2022

Biotech Stocks Facing FDA Decision In October 2022

Biotech Stocks Facing FDA Decision In September

Biotech Stocks Facing FDA Decision In September

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In June 2022

Latest Updates on COVID-19

Covid Conditions Improving Nationally In US, Data Shows

FDA Updates COVID-19 Test Policy; Asks Developers To Seek Premarket Review Pathways

Pfizer, BioNTech Apply For EUA In US Of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster In Kids

Synairgen Reports Positive 60 And 90-day Long COVID Data From Phase 3 SNG001 Trial; Stock Up

U.S. Covid Cases Fall 29% In Last Fortnight

Read More

COVID-19: Drugs in Development

RELATED NEWS

Sysco Q4 Profit Surges, Looks Ahead To Adj. Earnings Growth In FY23

Sysco Q4 22 Earnings Conference Call At 10:00 AM ET

Follow RTT

Editor's Pick
Most Read
Most Emailed

U.S. Consumer Sentiment Improves Less Than Previously Estimated In September

Chicago Business Barometer Unexpectedly Indicates Contraction In September

U.S. Personal Income Rises 0.3% In August, In Line With Estimates

Israel, Norway, Sweden Team Up With The BIS To Explore CBDC Payments

U.S. GDP Declines 0.6% In Q2, Unrevised From Previous Estimate

U.S. Weekly Jobless Claims Unexpectedly Dip To Five-Month Low

U.S. Pending Home Sales Slump More Than Expected In August

New York AG Sues Crypto Firms For Offering Unregistered Products

FDA Updates COVID-19 Test Policy; Asks Developers To Seek Premarket Review Pathways

Netflix Adding New Feature To Mobile Games

GM Delays Return-to-Office Plan After Employee Backlash

Tesla Q3 Vehicle Production, Deliveries Up

Teva To Pay $3.346 Mln To Settle Georgia's Price Fixing Claims

Axcella Reports Encouraging Interim Data From EMMPACT Study Of AXA1125

Worthington Industries Q1 Results Top Estimates; To Separate Steel Processing Business

Biotech Stocks Facing FDA Decision In October 2022

Rational AG Raises FY22 Guidance

Carnival Corp. Q3 Results Miss Estimates

Synthomer Now Sees Full Year EBITDA Below Previous Guidance - Quick Facts

Carnival Corp. Sinks Despite Lower Loss In Q3

Netflix Adding New Feature To Mobile Games

Regeneron : FDA Approves Dupixent For Prurigo Nodularis Treatment

FDA Updates COVID-19 Test Policy; Asks Developers To Seek Premarket Review Pathways

VF Corp. Revises FY23 Outlook Due To Lower-than-expected Q2 Results

Braemar Plc Expects H1 Revenue To Be Not Less Than £69 Mln

Tesla Q3 Vehicle Production, Deliveries Up

GM Delays Return-to-Office Plan After Employee Backlash

Vail Resorts Q4 Loss Narrows

Essentra To Sell Filters Business In A 262.1 Mln Pound Deal

ABB Inc. Invests $13 Mln In Iberville Site To Boost Production

Mortgage Rates Increase For 6th Consecutive Week

Prosus Reveals Termination Of $4.7 Bln Deal To Buy India's BillDesk

Rite Aid Q2 Adj. Loss Wider Than Estimates; Slashes FY23 Adj. Loss Outlook

Volkswagen Prices Porsche IPO At EUR 82.50/shr, High End Of Expected Range

UroGen Pharma Announces Label Change For JELMYTO - Quick Facts